VBIO Valion Bio, Inc.
Nasdaq · SEC CIK 1787740 · EDGAR
- Bought, last 12 months
- $28.4K 2 purchases by 2 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 57 since 2021-11-15, latest 2026-09-24 16:46
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Valauri Christina Rizopoulos | Dir | $18.0K | — |
| Bolton Sheryle | Dir | $10.4K | — |
| Ernst Jennifer | CEO, Dir | — | — |
| Wolf Lisa G | COO, CFO | — | — |
| Handley Michael K | COO | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-24 16:45 | 2026-09-18 | VBIO | Wolf Lisa G | COO, CFO | M - OptEx | — | +4 | 29 | +16% | — |
| D | 2026-09-24 16:45 | 2026-09-18 | VBIO | Wolf Lisa G | COO, CFO | F - Tax | $2.12 | -2 | 27 | -7% | -$4.24 |
| D | 2026-06-18 16:30 | 2026-06-18 | VBIO | Wolf Lisa G | CFO | M - OptEx | — | +92 | 618 | +17% | — |
| D | 2026-05-20 19:51 | 2026-05-18 | VBIO | Handley Michael K | CEO, Dir | M - OptEx | — | +2,206 | 11.0K | +25% | — |
| 2026-04-20 16:02 | 2026-04-15 | VBIO | Bolton Sheryle | Dir | P - Purchase | $1.04 | +10.0K | 10.0K | New | +$10.4K | |
| 2026-04-02 09:49 | 2026-04-01 | VBIO | Valauri Christina Rizopoulos | Dir | P - Purchase | $0.9478 | +19.0K | 19.0K | New | +$18.0K | |
| D | 2026-03-19 | 2026-03-18 | VBIO | Wolf Lisa G | CFO | M - OptEx | — | +92 | 526 | +21% | — |
| D | 2026-02-20 | 2026-02-18 | VBIO | Handley Michael K | COO | M - OptEx | — | +8,824 | 8,824 | New | — |
| D | 2025-12-22 | 2025-12-18 | VBIO | Ernst Jennifer | CEO, Dir | F - Tax | $1.87 | -5,262 | 32.7K | -14% | -$9,840 |
| D | 2025-12-22 | 2025-12-18 | VBIO | Ernst Jennifer | CEO, Dir | M - OptEx | — | +14.7K | 38.0K | +63% | — |
| D | 2025-12-22 | 2025-12-18 | VBIO | Wolf Lisa G | CFO | F - Tax | $1.87 | -302 | 434 | -41% | -$564.74 |
| D | 2025-12-22 | 2025-12-18 | VBIO | Wolf Lisa G | CFO | M - OptEx | — | +736 | 736 | New | — |
| 2025-09-24 | 2025-09-22 | VBIO | Ernst Jennifer | CEO, Dir | A - Grant | $0.00 | +22.5K | 23.2K | +3,193% | $0 | |
| 2024-03-22 | 2024-03-12 | VBIO | Bambach Kimberly Ann | Interim CFO | A - Grant | $0.00 | +7,500 | 7,500 | New | $0 | |
| DM | 2021-11-15 | 2021-11-12 | VBIO | Ernst Jennifer | CEO, Dir, 10% | C - Cnv Deriv | $0.00 | +28.4K | 1.17M | +2% | $0 |
Purchase Sale Sale after option exercise All abbreviations